Beyond dispensing: rethinking the pharmacist’s role in telemedicine
Article information
Dear Editor,
We read with great interest the article by Jung et al. [1] on pharmacists in telemedicine experiences. Pharmacists are now central to healthcare delivery, demonstrating irreplaceable value across diverse clinical and therapeutic fields [2–4]. We here highlight the challenges and research priorities.
TELEMEDICINE MARGINALIZATION AND PHARMACISTS’ PROFESSIONAL IDENTITY UNCERTAINTY
Jung et al. [1] found that pharmacists reported lower participation intention (67.0% vs. 84.7% for doctors). This may reflect telemedicine’s historical doctor-patient focus, which marginalizes pharmacists; limited prior experience and unclear role definitions are alternative explanations. Pharmacists prioritized chronic disease management, whereas doctors cited patient demand, suggesting a misalignment between pharmacists’ expectations and system design. As Jung et al. did not measure frustration or system support, these interpretations remain speculative.
Our analysis must be interpreted within Korea’s legal framework. The separation of prescribing and dispensing limits pharmacists’ independent clinical decision-making. Our proposed “online immediate response” does not imply autonomous prescribing or diagnosis, but structured medication counseling, adherence support, and adverse-effect screening, all requiring a valid prescription. AI-driven automated dispensing without pharmacist verification, or independent triage leading to dispensing, is not permitted under the Pharmacy and Medical Service Act. Our model therefore presupposes legal reforms or pilot exceptions.
TELEPHARMACY PRACTICE MODEL
Jung et al. reported 24% of cosmetic/hair-loss consultations lasted ≤3 minutes, suggesting overtreatment risk. We add that pharmacists’ exclusion causes counseling gaps, and such brevity may still demand extensive behind-the-scenes work, increasing burnout risk.
We propose a three-tiered integrated pharmacy practice model. Tier 1: online immediate response for real-time triage and structured counseling, enabled asynchronously after brief telemedicine encounters. Tier 2: risk-stratified referrals to physical clinics for comprehensive medication management, triggered by consultation brevity or polypharmacy rather than schedules. Tier 3: telepharmacy bridge services ensuring continuity across hospital and community settings, requiring inter-pharmacy information sharing and follow-up documentation, transforming pharmacists from episodic dispensers into continuous care coordinators. This hypothesis-generating model lacks pilot evidence; feasibility should be tested via pharmacist acceptance, referral completion, and error detection, enabled by shared records and handoffs under regulatory pilots.
TOWARD PROSPECTIVE STUDIES AND TECHNOLOGY-INTEGRATED PHARMACY PRACTICE
Telepharmacy’s effect on medication errors is unclear. Telepharmacy may reduce errors through reconciliation and monitoring, but may also create “digital errors” from communication constraints, technological failures, or workflow disruptions. Brief consultations (≤3 minutes) suggest counseling gaps, requiring prospective trials and broader error classifications. AI and 5G could support pharmacists, but AI-driven dispensing or autonomous triage remains legally impermissible in Korea; our recommendation is long-term and contingent on legal reform and pharmacist oversight.
FROM FEE-FOR-SERVICE TO VALUE-BASED TELEMEDICINE
Pharmacists’ telemedicine roles depend on payment reform: fee-for-service rewards volume, whereas value-based models need robust outcome measures. As 28.6% of pharmacists fear platform competition, Korea should first launch legal pilot programs defining permitted telepharmacy activities, temporarily waive delivery restrictions, and evaluate safety outcomes before full implementation.
Notes
CRedit authorship contributions
Liu-Cheng Li: writing - original draft, writing - review & editing; Yan Guan: writing - review & editing; Kai-Li Mao: writing - original draft, writing - review & editing
Conflicts of interest
The authors disclose no conflicts.
Funding
None
